Watching
$Iovance Biotherapeutics(IOVA.US$ February 24 PDUFA date. Also The company’s TIL therapy, lifileucel, for metastatic melanoma is under regulatory review and there have been no major issues identified. So with that and the pending lifileucel approval/launch expected in early 2024. Im pretty bullish on the even with the earnings miss![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
